Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Potent inhibitor of sAC shows potential as nonhormonal contraceptive

Sep. 27, 2021

Novel OSBPL7-targeting compounds show therapeutic efficacy in models of renal disease

Sep. 22, 2021

IP6K regulates circulating phosphate and intracellular ATP in mammals

Sep. 20, 2021

Combined inhibition of RIPK1 and ferroptosis as potential therapeutic strategy for AKI

Sep. 13, 2021

Opaganib significantly decreases kidney fibrosis in in vivo model

Sep. 8, 2021

4-PBA and TUDCA reduce symptoms in murine model of Alport syndrome

Sep. 7, 2021

Vertex Pharmaceuticals presents new apolipoprotein L1 inhibitors

Aug. 26, 2021

Serodus initiates phase II/III study of SER-150 in diabetic kidney disease

Aug. 25, 2021

First patient enrolled in trial on sirolimus drug-eluting balloon for erectile dysfunction

Aug. 19, 2021

RemeGen completes phase II study of telitacicept in IgAN

Aug. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026